Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma

Background. Renal cell carcinoma accounts for about 2-3% of all malignant tumors. The prevalence of brain metastases from RCC is less than 20% of cases. Traditionally, whole brain radiotherapy as well as the latest stereotactic radiosurgery improves both survival and local tumor control. These treat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Oncol Med
Main Authors: Roberto, Michela, Bassanelli, Maria, Iannicelli, Elsa, Giacinti, Silvana, D'Antonio, Chiara, Aschelter, Anna Maria, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698998/
https://ncbi.nlm.nih.gov/pubmed/26798533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/629046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados